Helping small biotech corporations navigate the steps in clinical research

Syreon works with small innovative biotech corporations to identify leading KOLs, and design and conduct agile, adaptive trials with key biomarkers and pharmacometrics.

Supporting medium-stage companies to speed phase 2 / 3 development

Syreon draws on its global expertise and clinical partnerships to design and execute innovative adaptive trials for regulatory submission with a compelling value dossier.

Conducting late phase research with global biotech and major pharma corporations

Studies linking hundreds of sites and enrolling thousands of patients in over 40 countries with long-term follow up to define treatment options, outcomes, health quality and costs.



Selecting the right Key Opinion Leaders is vital for any study. Through our extensive scientific contacts we draw global leaders in each disease to guide our studies and ensure world-class performance.


Quality is the key requirement for any program, without which all effort, investment and opportunities are jeopardized. Our Quality-by-Design strategies are built into every aspect of our operations to ensure success!


Accuracy and speed are critical to meet goals, to enable forward planning, and to control costs. We pay meticulous attention to ensure these are not competing priorities!


The scope and scale of our studies

Our studies scale easily and fluidly from small, first-in-man single-site studies of novel interventions incorporating molecular diagnostics to large-scale international studies of health outcomes and economic burden which may comprise 200 or more sites, last for up to 10 years, and include over 30,000 subjects with 100,000 patient years of care.


"Syreon is the most efficient CRO that we have ever worked with, we love your ClinStream system..."

— Senior PM, Global Pharma

"My deepest thank you to you and Syreon for delivering this work on time and so well done!..."

— VP, Global Pharma

"We would like to do all our trials with Syreon — they understand exactly what we need..."

— Medical Director, SME Biotech

"Just a wonderful experience — thank you Syreon for your expertise and your experienced team..."

— Project Director, Global Biotech

"We came straight to Syreon to rescue our study — we knew it would be done correctly!..."

— Scientific Director, Oncology SME

"Wonderful completion of a very important study! Your reporting is now the new standard for our company..."

— Medical Director, Global Pharma